Skip to content
The Policy VaultThe Policy Vault

Tibsovo (ivosidenib) — Medica

Central Nervous System Cancer (Oligodendroglioma or Astrocytoma)

Initial criteria

  • Patient is age ≥ 18 years
  • Patient has oligodendroglioma OR astrocytoma

Approval duration

1 year